Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization

Gangjian Qin, Masaaki Ii, Marcy Silver, Andrea Wecker, Evelyn Bord, Hong Ma, Mary Gavin, David A. Goukassian, Youngsup Yoon, Thalia Papayannopoulou, Takayuki Asahara, Marianne Kearney, Tina Thorne, Cynthia Curry, Liz Eaton, Lindsay Heyd, Deepika Dinesh, Raj Kishore, Yan Zhu, Douglas W. Losordo

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

The cell surface receptor α4 integrin plays a critical role in the homing, engraftment, and maintenance of hematopoietic progenitor cells (HPCs) in the bone marrow (BM). Down-regulation or functional blockade of α4 integrin or its ligand vascular cell adhesion molecule-1 mobilizes long-term HPCs. We investigated the role of α4 integrin in the mobilization and homing of BM endothelial progenitor cells (EPCs). EPCs with endothelial colony-forming activity in the BM are exclusively α4 integrin-expressing cells. In vivo, a single dose of anti-α4 integrin antibody resulted in increased circulating EPC counts for 3 d. In hindlimb ischemia and myocardial infarction, systemically administered anti-α4 integrin antibody increased recruitment and incorporation of BM EPCs in newly formed vasculature and improved functional blood flow recovery and tissue preservation. Interestingly, BM EPCs that had been preblocked with anti-α4 integrin ex vivo or collected from α4 integrin-deficient mice incorporated as well as control cells into the neovasculature in ischemic sites, suggesting that α4 integrin may be dispensable or play a redundant role in EPC homing to ischemic tissue. These data indicate that functional disruption of α4 integrin may represent a potential angiogenic therapy for ischemic disease by increasing the available circulating supply of EPCs. JEM

Original languageEnglish
Pages (from-to)153-163
Number of pages11
JournalJournal of Experimental Medicine
Volume203
Issue number1
DOIs
Publication statusPublished - 2006 Jan 23

Fingerprint

Integrins
Bone Marrow
Bone Marrow Cells
Hematopoietic Stem Cells
Tissue Preservation
Vascular Cell Adhesion Molecule-1
Antibodies
Cell Surface Receptors
Hindlimb
Endothelial Progenitor Cells
Down-Regulation
Ischemia
Cell Count
Myocardial Infarction
Maintenance
Ligands

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

Qin, Gangjian ; Ii, Masaaki ; Silver, Marcy ; Wecker, Andrea ; Bord, Evelyn ; Ma, Hong ; Gavin, Mary ; Goukassian, David A. ; Yoon, Youngsup ; Papayannopoulou, Thalia ; Asahara, Takayuki ; Kearney, Marianne ; Thorne, Tina ; Curry, Cynthia ; Eaton, Liz ; Heyd, Lindsay ; Dinesh, Deepika ; Kishore, Raj ; Zhu, Yan ; Losordo, Douglas W. / Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. In: Journal of Experimental Medicine. 2006 ; Vol. 203, No. 1. pp. 153-163.
@article{78d8c8d5e2254e7da33855dfdbd3c352,
title = "Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization",
abstract = "The cell surface receptor α4 integrin plays a critical role in the homing, engraftment, and maintenance of hematopoietic progenitor cells (HPCs) in the bone marrow (BM). Down-regulation or functional blockade of α4 integrin or its ligand vascular cell adhesion molecule-1 mobilizes long-term HPCs. We investigated the role of α4 integrin in the mobilization and homing of BM endothelial progenitor cells (EPCs). EPCs with endothelial colony-forming activity in the BM are exclusively α4 integrin-expressing cells. In vivo, a single dose of anti-α4 integrin antibody resulted in increased circulating EPC counts for 3 d. In hindlimb ischemia and myocardial infarction, systemically administered anti-α4 integrin antibody increased recruitment and incorporation of BM EPCs in newly formed vasculature and improved functional blood flow recovery and tissue preservation. Interestingly, BM EPCs that had been preblocked with anti-α4 integrin ex vivo or collected from α4 integrin-deficient mice incorporated as well as control cells into the neovasculature in ischemic sites, suggesting that α4 integrin may be dispensable or play a redundant role in EPC homing to ischemic tissue. These data indicate that functional disruption of α4 integrin may represent a potential angiogenic therapy for ischemic disease by increasing the available circulating supply of EPCs. JEM",
author = "Gangjian Qin and Masaaki Ii and Marcy Silver and Andrea Wecker and Evelyn Bord and Hong Ma and Mary Gavin and Goukassian, {David A.} and Youngsup Yoon and Thalia Papayannopoulou and Takayuki Asahara and Marianne Kearney and Tina Thorne and Cynthia Curry and Liz Eaton and Lindsay Heyd and Deepika Dinesh and Raj Kishore and Yan Zhu and Losordo, {Douglas W.}",
year = "2006",
month = "1",
day = "23",
doi = "10.1084/jem.20050459",
language = "English",
volume = "203",
pages = "153--163",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "1",

}

Qin, G, Ii, M, Silver, M, Wecker, A, Bord, E, Ma, H, Gavin, M, Goukassian, DA, Yoon, Y, Papayannopoulou, T, Asahara, T, Kearney, M, Thorne, T, Curry, C, Eaton, L, Heyd, L, Dinesh, D, Kishore, R, Zhu, Y & Losordo, DW 2006, 'Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization', Journal of Experimental Medicine, vol. 203, no. 1, pp. 153-163. https://doi.org/10.1084/jem.20050459

Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. / Qin, Gangjian; Ii, Masaaki; Silver, Marcy; Wecker, Andrea; Bord, Evelyn; Ma, Hong; Gavin, Mary; Goukassian, David A.; Yoon, Youngsup; Papayannopoulou, Thalia; Asahara, Takayuki; Kearney, Marianne; Thorne, Tina; Curry, Cynthia; Eaton, Liz; Heyd, Lindsay; Dinesh, Deepika; Kishore, Raj; Zhu, Yan; Losordo, Douglas W.

In: Journal of Experimental Medicine, Vol. 203, No. 1, 23.01.2006, p. 153-163.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Functional disruption of α4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization

AU - Qin, Gangjian

AU - Ii, Masaaki

AU - Silver, Marcy

AU - Wecker, Andrea

AU - Bord, Evelyn

AU - Ma, Hong

AU - Gavin, Mary

AU - Goukassian, David A.

AU - Yoon, Youngsup

AU - Papayannopoulou, Thalia

AU - Asahara, Takayuki

AU - Kearney, Marianne

AU - Thorne, Tina

AU - Curry, Cynthia

AU - Eaton, Liz

AU - Heyd, Lindsay

AU - Dinesh, Deepika

AU - Kishore, Raj

AU - Zhu, Yan

AU - Losordo, Douglas W.

PY - 2006/1/23

Y1 - 2006/1/23

N2 - The cell surface receptor α4 integrin plays a critical role in the homing, engraftment, and maintenance of hematopoietic progenitor cells (HPCs) in the bone marrow (BM). Down-regulation or functional blockade of α4 integrin or its ligand vascular cell adhesion molecule-1 mobilizes long-term HPCs. We investigated the role of α4 integrin in the mobilization and homing of BM endothelial progenitor cells (EPCs). EPCs with endothelial colony-forming activity in the BM are exclusively α4 integrin-expressing cells. In vivo, a single dose of anti-α4 integrin antibody resulted in increased circulating EPC counts for 3 d. In hindlimb ischemia and myocardial infarction, systemically administered anti-α4 integrin antibody increased recruitment and incorporation of BM EPCs in newly formed vasculature and improved functional blood flow recovery and tissue preservation. Interestingly, BM EPCs that had been preblocked with anti-α4 integrin ex vivo or collected from α4 integrin-deficient mice incorporated as well as control cells into the neovasculature in ischemic sites, suggesting that α4 integrin may be dispensable or play a redundant role in EPC homing to ischemic tissue. These data indicate that functional disruption of α4 integrin may represent a potential angiogenic therapy for ischemic disease by increasing the available circulating supply of EPCs. JEM

AB - The cell surface receptor α4 integrin plays a critical role in the homing, engraftment, and maintenance of hematopoietic progenitor cells (HPCs) in the bone marrow (BM). Down-regulation or functional blockade of α4 integrin or its ligand vascular cell adhesion molecule-1 mobilizes long-term HPCs. We investigated the role of α4 integrin in the mobilization and homing of BM endothelial progenitor cells (EPCs). EPCs with endothelial colony-forming activity in the BM are exclusively α4 integrin-expressing cells. In vivo, a single dose of anti-α4 integrin antibody resulted in increased circulating EPC counts for 3 d. In hindlimb ischemia and myocardial infarction, systemically administered anti-α4 integrin antibody increased recruitment and incorporation of BM EPCs in newly formed vasculature and improved functional blood flow recovery and tissue preservation. Interestingly, BM EPCs that had been preblocked with anti-α4 integrin ex vivo or collected from α4 integrin-deficient mice incorporated as well as control cells into the neovasculature in ischemic sites, suggesting that α4 integrin may be dispensable or play a redundant role in EPC homing to ischemic tissue. These data indicate that functional disruption of α4 integrin may represent a potential angiogenic therapy for ischemic disease by increasing the available circulating supply of EPCs. JEM

UR - http://www.scopus.com/inward/record.url?scp=31344476738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31344476738&partnerID=8YFLogxK

U2 - 10.1084/jem.20050459

DO - 10.1084/jem.20050459

M3 - Article

VL - 203

SP - 153

EP - 163

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 1

ER -